Drug Type Antibody fusion proteins |
Synonyms |
Target |
Mechanism GITR inhibitors(Glucocorticoid-induced tumor necrosis factor receptor-related protein inhibitors), IL-15 inhibitors(Interleukin-15 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization MediMabBio Co., Ltd.Startup |
Active Organization MediMabBio Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | KR | MediMabBio Co., Ltd.Startup | 03 Jun 2024 |